Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07570264Not ApplicableRecruiting

LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory Trial

Role: lead

NCT06117813Not ApplicableCompleted

Visual Perceptual Learning Based Digital Therapeutics for Stereopsis in Intermittent Exotropia

Role: lead

NCT06160726Completed

MRI-based Artificial Intelligence Software (NNS-SOT) for Onset Time Estimation in Lesion With Acute Ischemic Stroke

Role: lead

NCT05525949Not ApplicableCompleted

Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke

Role: lead

NCT04102605Not ApplicableCompleted

Visual Perceptual Learning for the Treatment of Visual Field Defect

Role: lead

All 5 trials loaded